Incidences of newly detected retinal breaks and retinal detachments (RDs) are quite significant following acute posterior vitreous detachment (PVD), reveals a study, suggesting that repeat examination may be necessary in these patients.
Deep learning models accurately identify eyes with glaucomatous visual field damage (GVFD) and predict functional loss severity from spectral domain optical coherence tomography (SD OCT) images, reports a study.
Treatment with teprotumumab in patients with active thyroid eye disease confers beneficial effects on proptosis, Clinical Activity Score, diplopia and quality of life, without increasing the incidence of serious adverse events, according to the results of a phase III trial.
Use of biologic agents in eyes with refractory, active, noninfectious intermediate uveitis, posterior uveitis or panuveitis (NIPPU) is associated with satisfactory disease control, reduced use of systemic immunosuppression, stable visual acuity and a 23.7-percent risk of disease relapse, reveals a study.
A suprachoroidally injected CLS-TA, an investigational formulation of triamcinolone acetonide, yields significant improvements in vision of patients with macular oedema, according to the results of the phase III PEACHTREE study.
Switching from efavirenz/emtricitabine/tenofovir disoproxil fumarate (EFV/FTC/TDF) to the new bictegravir/ emtricitabine/tenofovir alafenamide (BIC/FTC/TAF) regimen maintained high rates of virological suppression in adults who are living with HIV*, according to a study presented at AIDS 2020.
Among individuals with abdominal obesity, drinking beverages with artificial sweeteners (ASBs) or no sugar (USBs) instead of sugar-sweetened beverages (SSBs) helps lose body weight, a study has found. However, USBs have a more favourable effect on sweet taste preference compared with ASBs.
Pre-exposure prophylaxis (PrEP) containing either long-acting injectable cabotegravir (CAB) or tenofovir/emtricitabine (TDF/FTC) is safe and effective for transgender women (TGW) and cisgender men who have sex with men (MSM), but CAB results in a much lower HIV incidence compared to TDF/FTC, results of the HIV Prevention Trials Network (HPTN) 083 have shown.
Monthly prophylaxis with the fixed-dose combination of naphthoquine-azithromycin (NQAZ) is well tolerated and confers significant protection against infection with Plasmodium parasites among individuals residing in malaria-endemic areas in Southeast Asia, as shown in the results of a phase III trial.